{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:16:56Z","timestamp":1758586616032,"version":"3.44.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Mitsugumin 53 (MG53), a member of the tripartite motif family proteins, is predominantly expressed in skeletal and cardiac muscles. Endogenous MG53 was first identified as a crucial component of the sarcolemmal membrane repair machinery. In cardiac muscles, MG53 prevented against ischemia\/reperfusion-induced myocardial injury. Recent research has demonstrated that native MG53 is present in and performs significant functions within various non-striated muscle tissues, including lung epithelial cells, the inner cortex of the kidney, macrophages, aortic valves, corneal epithelial cells, as well as in the tear film and aqueous humor. These studies indicate a potential application of recombinant human MG53 (rhMG53) in various disease models. To date, an increasing number of studies have confirmed that rhMG53 exhibits broad protective effects in skeletal muscle injury, cardiovascular diseases, and other multiple-organ injuries. In this review, we clarify the therapeutic functions of rhMG53 and the molecular mechanisms involved in multiple organ injuries, emphasizing the development of rhMG53 protein as a potential therapeutic agent for treating a range of diseases.<\/jats:p>","DOI":"10.3389\/fphar.2025.1625232","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:28:18Z","timestamp":1758518898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Recombinant human mitsugumin 53: a potential therapeutic agent for multiple diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Junfeng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e009960","DOI":"10.1161\/JAHA.118.009960","article-title":"MG53 protein protects aortic valve interstitial cells from membrane injury and fibrocalcific remodeling","volume":"8","author":"Adesanya","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1001\/jamaneurol.2013.469","article-title":"TRIM proteins in therapeutic membrane repair of muscular dystrophy","volume":"70","author":"Alloush","year":"2013","journal-title":"JAMA Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2119\/molmed.2011.00084","article-title":"Translational research and therapeutic perspectives in dysferlinopathies","volume":"17","author":"Barthelemy","year":"2011","journal-title":"Mol. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1038\/s41467-019-12483-0","article-title":"Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function","volume":"10","author":"Bian","year":"2019","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ncb1812","article-title":"MG53 nucleates assembly of cell membrane repair machinery","volume":"11","author":"Cai","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1161\/CIRCULATIONAHA.110.954628","article-title":"MG53 constitutes a primary determinant of cardiac ischemic preconditioning","volume":"121","author":"Cao","year":"2010","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s42003-019-0316-7","article-title":"MG53 promotes corneal wound healing and mitigates fibrotic remodeling in rodents","volume":"2","author":"Chandler","year":"2019","journal-title":"Commun. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12931-020-01384-2","article-title":"TRIM72 promotes alveolar epithelial cell membrane repair and ameliorates lung fibrosis","volume":"21","author":"Cong","year":"2020","journal-title":"Respir. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"114299","DOI":"10.1016\/j.intimp.2025.114299","article-title":"Liver ischemia reperfusion injury: mechanisms, cellular pathways, and therapeutic approaches","volume":"150","author":"de Oliveira","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1111\/jcmm.16777","article-title":"MG53 inhibits angiogenesis through regulating focal adhesion kinase signalling","volume":"25","author":"Dong","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"279ra36","DOI":"10.1126\/scitranslmed.3010755","article-title":"MG53-mediated cell membrane repair protects against acute kidney injury","volume":"7","author":"Duann","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-023-01458-9","article-title":"E3 ligase MG53 suppresses tumor growth by degrading cyclin D1","volume":"8","author":"Fang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1165\/rcmb.2012-0374OC","article-title":"Persistence of LPS-induced lung inflammation in surfactant protein-C-deficient mice","volume":"49","author":"Glasser","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.redox.2022.102357","article-title":"MG53 preserves mitochondrial integrity of cardiomyocytes during ischemia reperfusion-induced oxidative stress","volume":"54","author":"Gumpper-Fedus","year":"2022","journal-title":"Redox Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/milmed\/usaa357","article-title":"Recombinant human MG53 protein protects against alkaline-induced corneal injuries in mice","volume":"186","author":"Guo","year":"2021","journal-title":"Mil. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.7150\/ijbs.67869","article-title":"MG53 inhibits cellular proliferation and tumor progression in colorectal carcinoma","volume":"18","author":"Gupta","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.ymthe.2017.06.025","article-title":"Treatment with recombinant human MG53 protein increases membrane integrity in a mouse model of limb girdle muscular dystrophy 2B","volume":"25","author":"Gushchina","year":"2017","journal-title":"Mol. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2021.10.017","article-title":"Membrane-delimited signaling and cytosolic action of MG53 preserve hepatocyte integrity during drug-induced liver injury","volume":"76","author":"Han","year":"2022","journal-title":"J. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tibs.2017.01.002","article-title":"TRIM family proteins: roles in autophagy, immunity, and carcinogenesis","volume":"42","author":"Hatakeyama","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1038\/ncomms5387","article-title":"Treatment of acute lung injury by targeting MG53-mediated cell membrane repair","volume":"5","author":"Jia","year":"2014","journal-title":"Nat. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e01049","DOI":"10.1002\/prp2.1049","article-title":"MG53: a potential therapeutic target for kidney disease","volume":"11","author":"Ke","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1164\/rccm.202007-2908LE","article-title":"Recombinant MG53 protein protects mice from lethal influenza virus infection","volume":"203","author":"Kenney","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"L449","DOI":"10.1152\/ajplung.00172.2014","article-title":"TRIM72 is required for effective repair of alveolar epithelial cell wounding","volume":"307","author":"Kim","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-021-01418-3","article-title":"MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer","volume":"20","author":"Li","year":"","journal-title":"Mol. Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/cells10010122","article-title":"MG53, a tissue repair protein with broad applications in regenerative medicine","volume":"10","author":"Li","year":"","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.kint.2021.09.027","article-title":"The cell membrane repair protein MG53 modulates transcription factor NF-\u03baB signaling to control kidney fibrosis","volume":"101","author":"Li","year":"","journal-title":"Kidney Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/jcmm.16917","article-title":"MG53 attenuates nitrogen mustard-induced acute lung injury","volume":"26","author":"Li","year":"","journal-title":"J. Cell. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.yjmcc.2014.12.010","article-title":"Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury","volume":"80","author":"Liu","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1161\/CIRCULATIONAHA.118.029413","article-title":"MG53, A novel regulator of KChIP2 and Ito,f, plays a critical role in electrophysiological remodeling in cardiac hypertrophy f, plays a critical role in electrophysiological remodeling in cardiac hypertrophy","volume":"139","author":"Liu","year":"2019","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41401-020-0420-8","article-title":"MG53 protects against contrast-induced acute kidney injury by reducing cell membrane damage and apoptosis","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41389-022-00414-6","article-title":"The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling","volume":"11","author":"Ma","year":"2022","journal-title":"Oncogenesis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ncb0109-7","article-title":"Membrane repair redux: redox of MG53","volume":"11","author":"McNeil","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"B34","first-page":"1097","article-title":"Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage","volume":"140","author":"McNeil","year":"1992","journal-title":"Am. J. Pathol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1165\/rcmb.2017-0364OC","article-title":"Inhaled TRIM72 protein protects ventilation injury to the lung through injury-guided cell repair","volume":"59","author":"Nagre","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1074\/jbc.M113.525154","article-title":"Mitsugumin 53 (MG53) ligase ubiquitinates focal adhesion kinase during skeletal myogenesis","volume":"289","author":"Nguyen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2413","article-title":"TRIM family proteins and their emerging roles in innate immunity","volume":"8","author":"Ozato","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.3390\/ijms25115572","article-title":"Limb girdle muscular dystrophy type 2B (LGMD2B): diagnosis and therapeutic possibilities","volume":"25","author":"Poudel","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1038\/s41467-020-17177-6","article-title":"MG53 suppresses interferon-beta and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling","volume":"11","author":"Sermersheim","year":"2020","journal-title":"Nat. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature11834","article-title":"Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders","volume":"494","author":"Song","year":"2013","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.5483\/bmbrep.2016.49.8.079","article-title":"Dual function of MG53 in membrane repair and insulin signaling","volume":"49","author":"Tan","year":"2016","journal-title":"BMB Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1093\/eurheartj\/ehae466","article-title":"European society of cardiology: the 2023 atlas of cardiovascular disease statistics","volume":"45","author":"Timmis","year":"2024","journal-title":"Eur. Heart J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/mi.2014.6","article-title":"An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1\/Th2 nitrative stress in human severe asthma","volume":"7","author":"Voraphani","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCRESAHA.109.215822","article-title":"Cardioprotection of ischemia\/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair","volume":"107","author":"Wang","year":"2010","journal-title":"Circ. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2337\/db19-0807","article-title":"MG53 does not manifest the development of diabetes in db\/db mice","volume":"69","author":"Wang","year":"2020","journal-title":"Diabetes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e148375","DOI":"10.1172\/jci.insight.148375","article-title":"MG53 suppresses NF-\u03baB activation to mitigate age-related heart failure","volume":"6","author":"Wang","year":"2021","journal-title":"JCI Insight"},{"key":"B47","doi-asserted-by":"publisher","first-page":"102118","DOI":"10.1016\/j.tranon.2024.102118","article-title":"MG53 suppresses tumor growth via transcriptional inhibition of KIF11 in pancreatic cancer","volume":"50","author":"Wang","year":"2024","journal-title":"Transl. Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"139ra85","DOI":"10.1126\/scitranslmed.3003921","article-title":"Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy","volume":"4","author":"Weisleder","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/2321-3868.123074","article-title":"Mitsugumin 53 protects the kidney from severe burn injury in mice","volume":"1","author":"Wu","year":"2013","journal-title":"Burns Trauma"},{"key":"B50","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/CIRCULATIONAHA.118.037216","article-title":"Glucose-sensitive myokine\/cardiokine MG53 regulates systemic insulin response and metabolic homeostasis","volume":"139","author":"Wu","year":"2019","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"617845","DOI":"10.3389\/fphys.2020.617845","article-title":"Serum MG53\/TRIM72 is associated with the presence and severity of coronary artery disease and acute myocardial infarction","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Physiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"596107","DOI":"10.3389\/fcvm.2020.596107","article-title":"Prognostic value of circulating MG53 levels in acute myocardial infarction","volume":"7","author":"Xie","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1111\/jcmm.13171","article-title":"MG53 anchored by dysferlin to cell membrane reduces hepatocyte apoptosis which induced by ischaemia\/reperfusion injury in vivo and in vitro","volume":"21","author":"Yao","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1038\/ncomms3354","article-title":"MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling","volume":"4","author":"Yi","year":"2013","journal-title":"Nat. Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e1805492","DOI":"10.1002\/smll.201805492","article-title":"MG53 inhibits the progression of tongue cancer cells through regulating PI3K-AKT signaling pathway: evidence from 3D cell culture and animal model","volume":"15","author":"Yin","year":"2019","journal-title":"Small"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e70439","DOI":"10.1111\/jcmm.70439","article-title":"Mitsugumin 53 inhibits angiogenesis through regulating focal adhesion turnover and tip cell formation","volume":"29","author":"Yuan","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2337\/db24-0556","article-title":"Friend or foe: the paradoxical roles of MG53 in diabetes","volume":"74","author":"Yuan","year":"2025","journal-title":"Diabetes"},{"key":"B58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/cvr\/cvr029","article-title":"MG53 participates in ischaemic postconditioning through the RISK signalling pathway","volume":"91","author":"Zhang","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1124\/mol.117.108241","article-title":"MG53: biological function and potential as a therapeutic target","volume":"92","author":"Zhang","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13578-021-00629-x","article-title":"Cardiac effects and clinical applications of MG53","volume":"11","author":"Zhong","year":"2021","journal-title":"Cell Biosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/mus.24619","article-title":"Amelioration of ischemia-reperfusion-induced muscle injury by the recombinant human MG53 protein","volume":"52","author":"Zhu","year":"2015","journal-title":"Muscle Nerve"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1625232\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:28:18Z","timestamp":1758518898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1625232\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":61,"alternative-id":["10.3389\/fphar.2025.1625232"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1625232","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"article-number":"1625232"}}